Electronic structure of highly ruffled low-spin iron(III) porphyrinates with electron withdrawing heptafluoropropyl groups at the meso positions.

Bis(pyridine)[meso-tetrakis(heptafluoropropyl)porphyrinato]iron(III), [Fe(THFPrP)Py(2)](+), was reported to be the low-spin complex that adopts the purest (d(xz), d(yz))(4)(d(xy))(1) ground state where the energy gap between the iron d(xy) and d(π)(d(xz), d(yz)) orbitals is larger than the corresponding energy gaps of any other complexes reported previously (Moore, K. T.; Fletcher, J. T.; Therien, M. J. J. Am. Chem. Soc. 1999, 121, 5196-5209). Although the highly ruffled porphyrin core expected for this complex contributes to the stabilization of the (d(xz), d(yz))(4)(d(xy))(1) ground state, the strongly electron withdrawing C(3)F(7) groups at the meso positions should stabilize the (d(xy))(2)(d(xz), d(yz))(3) ground state. Thus, we have reexamined the electronic structure of [Fe(THFPrP)Py(2)](+) by means of (1)H NMR, (19)F NMR, and electron paramagnetic resonance (EPR) spectroscopy. The CD(2)Cl(2) solution of [Fe(THFPrP)Py(2)](+) shows the pyrrole-H signal at -10.25 ppm (298 K) in (1)H NMR, the CF(2)(α) signal at -74.6 ppm (298 K) in (19)F NMR, and the large g(max) type signal at g = 3.16 (4.2 K) in the EPR. Thus, contrary to the previous report, the complex is unambiguously shown to adopt the (d(xy))(2)(d(xz), d(yz))(3) ground state. Comparison of the spectroscopic data of a series of [Fe(THFPrP)L(2)](+) with those of the corresponding meso-tetrapropylporphyrin complexes [Fe(TPrP)L(2)](+) with various axial ligands (L) has shown that the meso-C(3)F(7) groups stabilize the (d(xy))(2)(d(xz), d(yz))(3) ground state. Therefore, it is clear that the less common (d(xz), d(yz))(4)(d(xy))(1) ground state can be stabilized by the three major factors: (i) axial ligand with low-lying π* orbitals, (ii) ruffled porphyrin ring, and (iii) electron donating substituent at the meso position.

[Early diagnostic biomarker for Alzheimer's disease now and in the future].

Alzheimer's disease is thought to be "common disease". It is expected that new biological diagnostic marker will be discovered for Alzheimer's disease. There are two roles in diagnostic biomarker for AD.: one is a screening and the other one is to help definite diagnosis for AD. Simple screening method using touch panel type computer (Forgetfulness consultation program) is most useful of screening tools and phosphorylated tau protein in cerebrospinal fluid is highly appreciated as a diagnostic biomarker to help definite diagnosis. Serum WGA binding transferrin in AD is significantly higher than that in controls and high levels of it proceed increased levels of amyloid beta protein. Serum WGA binding transferrin may be useful for early diagnostic biomarker in serum.